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Abstract
Background: Echogenic intracardiac focus (EIF) has been identified as a common ultrasound
finding in association with fetal aneuploidy. Little is known about the association of this soft marker
aneuploidy in various ethnic groups. Although it is commonly thought Asians in general have a
higher incidence of EIF, it is unknown whether this also applies to Japanese as a subpopulation. The
purpose of this study is to determine the antenatal incidence and postnatal significance of EIF
observed during sonography in Japanese patients.
Methods: A cohort of Japanese patients who underwent ultrasound screening from 1997 to 1999
in the ultrasound unit at the New York University School of Medicine was identified. Variables
included age, gestational age, serum markers, and the presence or absence of aneuploidy. Patients
with first degree paternal or maternal Japanese ancestry were included for analysis. Examinations
were performed between 14 and 24 weeks gestation. The prevalence of EIF was calculated. The
control group was based on previously published data in the U.S (7.3% prevalence).
Results: A total of 154 subjects were identified, 148 were available for final analysis. Twenty-two
fetuses had an EIF, 19 (86.4%) left-sided, 3 (13.6%) right-sided. Seventeen patients had other
sonographic markers associated with aneuploidy. The mean maternal age at diagnosis was 30.7 ±
3.9 years and the mean gestational age was 19.8 ± 1.6 weeks. The prevalence of EIF was 14.8%.
Compared to published population prevalence, there was a statistically significant difference (p <
0.005). No abnormal karyotypes were found.
Conclusion: Asians of Japanese origin may have a higher prevalence of echogenic intracardiac foci,
thus affecting the positive predictive value of this sonographic marker for aneuploidy.
Background
The population frequency of chromosomal anomalies at
birth is 1 in 165 [1]. Hook in 1981 established the rela-
tionship between advanced maternal age and fetal aneu-
ploidy [2]. Using advanced maternal age (i.e. >35 years
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old) as the only screening method, 80% of fetal aneu-
ploidy will be missed [1].
Technological advances in ultrasonography have allowed
an increase in the prenatal detection of structural findings
associated with aneuploidy. Recently, subtle ultrasound
findings have been adopted as potential genetic markers
for aneuploidy thus adjusting the overall maternal age
related risk. The most common of such markers for aneu-
ploidy include: echogenic intracardiac focus (EIF), echo-
genic bowel (EB), choroid plexus cyst (CPC), shortened
long bones (femur and humerus), and renal pyelectasis
(RP). The majority of these "soft markers" are associated
with an increased risk of trisomy 21, with the exception of
the CPC, which is more specific for trisomy 18 [3], and EIF
for trisomy 21 and 13 [4].
There is conflicting evidence in the literature regarding not
only the management of isolated ultrasound "soft mark-
ers" in low risk populations, but also their potential asso-
ciation with aneuploidy, particularly EIF [5,6]. There is a
paucity of information in the literature regarding the prev-
alence of these markers in different racial or ethnic groups,
as well as other possible confounders of this tool [7].
The current study was performed to determine the rate of
echogenic intracardiac foci in patients of Japanese ances-
try and the difference between Japanese patients and a
racially mixed general population.
Methods
This study was approved by the Institutional Review
Board at the New York University School of Medicine. A
cohort of patients who presented for midtrimester ultra-
sound evaluation to the New York University School of
Medicine was analyzed over a 3-year period from 1997 –
1999. Data was abstracted from the patient's prenatal
records and our ultrasound database.
Inclusion criteria included patients of first degree Japanese
ancestry, estimated gestational age between 14 and 24
weeks, and a finding of EIF regardless of presence or
absence of other "soft markers". Exclusion criteria
included the presence of major anomalies and unavaila-
bility of karyotypic analysis.
The variables analyzed included age, gestational age at
ultrasound screening, biochemical serum markers, the
presence or absence of aneuploidy, the presence or
absence of EIF. Per protocol in our ultrasound unit, pres-
ence or absence of markers for aneuploidy is routinely
noted on ultrasound reports. The total number of fetal
anatomy ultrasounds performed during this time period
and the number of amniocenteses were also assessed.
Sonographic examination for the detection of congenital
anomalies was performed between 14 and 24 weeks ges-
tation using Acuson 128XP (Acuson, Mountain View CA).
All sonographic evaluations were performed by two oper-
ators for each patient: the first was a sonographer certified
in obstetrical ultrasound (SM), the second was a maternal
fetal medicine attending (AR). The patient's ethnic back-
ground was determined by self-reporting on the prenatal
patient record. The patients were presented with a list of
choices including: African, Asian, Indian, Hispanic, Cau-
casian, or other. Patients with first degree relationship of
either paternal or maternal Japanese ancestry were identi-
fied among self-reported Asian patients at the time of
ultrasound. At our institution, sub-ethnicity identification
is routine at the time of ultrasound in patients with sono-
graphic abnormalities.
Echogenic intracardiac foci were defined as echogenic foci
found in either or both ventricles on either an apical or
lateral four-chamber view. Per protocol, to qualify as an
echogenic focus, the dot had to be as bright as bone [8].
Other markers for aneuploidy were defined as follows:
pyelectasis – renal pelvis ≥5 mm; short femur and short
humerus – ≥10 day lag in growth.
The prevalence of EIF was calculated for our study cohort.
The control group EIF prevalence of 7.33% was based on
previously published data in the U.S. In a meta-analysis
by Smith-Bindman in 2001 [9], a total of five studies
[8,10-13] were examined that included evaluations of EIF.
The total number of subjects was 5,948 with a total
number of 436 subjects or 7.33% (95% CI 6.64, 7.96)
having the finding of EIF.
Karyotypes were determined by the cytogenetics labora-
tory at NYU School of Medicine. Infants at birth were
assessed by attending pediatricians for stigmata of Down
syndrome and selective genetic analysis in the postnatal
period was performed at the physician's discretion. Chi-
square analysis was performed using a personal computer
and statistical software (SPSS, Chicago, IL).
Table 1: Incidence of other sonographic anomalies associated 
with aneuploidy in the study group.
Anomaly Prevalence
Renal Pyelectasis 9
Choroid Plexus cysts 6
Short femur and humerus 1
Hypoplastic Phalanx 1
Nuchal Fold (>6 mm) 0
VSD 1
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Results
A total of 154 patients of Japanese ancestry underwent tar-
geted ultrasound screening during the study period. Five
patients were excluded from final analysis due to limited
follow up secondary to transfer of care (1/5) or moving
out of the country (4/5). There were 149 patients available
for analysis which included 148 singleton pregnancies
and 1 twin gestation. The mean maternal age at diagnosis
was 30.7 ± 3.9 years and the mean gestational age at diag-
nosis was 19.8 weeks. Twenty-two fetuses were identified
with an EIF, 19 (86.4%) were left-sided, 3 (13.6%) were
right-sided. Two fetuses had multiple foci, one had three
calcifications and the other one had two calcifications.
One patient had a spontaneous preterm delivery at 21
weeks gestation. Seventeen patients (89.4%) were identi-
fied with other sonographic markers associated with ane-
uploidy, in addition to EIF (Table 1). There were no
abnormal karyotypes among the study population. There
were no patients in the study group with abnormal results
of maternal serum screening.
The prevalence of EIF in our study cohort was 14.8%.
When compared to a previously published prevalence of
7.3%, there was a statistically significant difference (p <
0.005).
Discussion
Schechter, in 1987, was the first author to note a hypere-
choic focus within the left ventricular chamber that was
associated with the chordae tendinae [4]. In a 1994 review
of three fetuses with sonographic and pathologic correla-
tion, Brown et. al. [15] found that EIF represents papillary
muscle mineralization within the fetal heart.
Bromley et. al. in 1995 reported a 4.9% incidence of EIF
among 1334 patients studied. They also found that 18%
of fetuses with trisomy 21 had an EIF and that sono-
graphic identification of an EIF had a fourfold increase
risk of trisomy 21 [8]. Petrikovsky et. al. in 1995 reported
a 3.6% incidence of EIF in 1139 patients, all of whom had
a normal karyotype. The subjects in this study were not
stratified by ethnic origin. Interestingly, the echogenic
focus was present in all infants who underwent echocardi-
ographic examination within the first three months of life
[16]. In 1996, the same author failed to find any correla-
tion between unusually appearing echogenic foci and
adverse perinatal outcome [17].
Bromley et. al., in 1997, incorporated maternal age and
the presence of EIF in the sonographic scoring index for
the detection of trisomy 21 [13]. The same group in 1998
reported a 4.8% incidence of aneuploidy in 290 fetuses
that had an EIF. In that study the incidence of aneuploidy
in patients less than 35 years old was 3.6%. Only one of
the 14 aneuploid fetuses had an echogenic intracardiac
focus as the only sonographic marker, and this occurred in
a woman older than 35 years [18]. Bromley, in 2002,
reported similar findings focusing on the likelihood ratios
(LR). With an isolated finding of EIF, there was a non-sig-
nificant LR of 1.4 (95%CI 0.6 – 4.3) as compared to con-
trols [19].
Smith-Bindman et. al., in a 2001 meta-analysis (a total of
56 studies describing 1930 fetuses with Down syndrome
and 130,365 unaffected fetuses were included) of second
trimester ultrasound to detect Down syndrome deter-
mined that when ultrasonographic markers were
observed without associated fetal structural malforma-
tions, sensitivity for each one was low (range, 1%–16%),
and most fetuses with such markers had normal outcomes
[9]. Of the 5 studies in the meta-analysis that specifically
looked at EIF there were a total of 5948 patients, 7.3% of
whom had EIF.
In 2000, Shipp et. al. [7] reported on EIF and its correla-
tion to maternal race. They reported a 30.4% prevalence
of EIF in Asian patients. There, however, were only 46
(489 total patients) patients in the Asian cohort of their
study. Additionally, there was no stratification of Asian
patients into various geographic origins. So, it is not
known whether they were mainly Japanese or mainly
composed of patients of other Asian origin. The current
study focuses on Japanese patients only and with a larger
sample (148 vs. 49).
A recent meta-analysis by Sotiriadis, et. al [20], evaluated
all comers races with eleven studies for a total of 51,831
pregnancies. Positive and negative likelihood ratios for an
isolated finding of EIF were 5.4 and 0.81, respectively.
Specificity was approximately 96%. However, a weakness
of this meta-analysis is that many of the studies selected
were of high risk subjects. In 2001, Nyberg [21] evaluated
the ultrasound findings in 186 fetuses with trisomy 21
and 8728 controls. EIF was the most common marker
found among affected fetuses after exclusion of major
anomalies (7.1%). The positive LR for an isolated finding
if EIF was 1.8. It is not clear why this is significantly lower
than that found in the meta-analysis by Sotiriadis as it
appears they both evaluated subjects of similar risk. The
most likely explanation is the data from the meta-analysis
more likely represents the true population given the larger
numbers.
Limitations of the current study include a small sample
size, the retrospective nature of the review, and the use of
a meta-analysis sample that may not be truly representa-
tive of the general population. In general, studies of EIF
are limited by factors such as technique, experience, and
equipment. Our preliminary results revealed no increase
in the incidence of aneuploidy despite an increased inci-BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/12
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dence of EIF. As there is not conclusive evidence in the lit-
erature that links isolated EIF to an increased risk of
aneuploidy in low risk populations. Caution should be
exerted when counseling these patients regarding these
findings until there is general expert consensus or conclu-
sive scientific evidence regarding this issue.
Conclusions
We report a 14.8% prevalence of EIF in patients of Japa-
nese ancestry. When compared to a previously reported
incidence of 7.3% in other low risk groups [9], there is a
statistically significant difference. We identified a homo-
geneous ethnic group which may allow for a more conclu-
sive analysis of this sub-population rather than broader
groups based on racial dispositions. We conclude that
there is an increased prevalence of EIF in patients of Japa-
nese ancestry. Additionally, the positive predictive value
for detecting aneuploidy in Japanese patients is likely even
lower than other populations based on its higher preva-
lence. It is important to consider the LR of EIF both as an
isolated and combined finding when counseling patients
for invasive genetic diagnosis. Based on these results, inva-
sive prenatal diagnosis for an isolated EIF in Japanese
patients may not be warranted.
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